⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Colonoscopy Followup After Positive Fecal Occult Blood Test- Understanding Barriers to Adherence

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Colonoscopy Followup After Positive Fecal Occult Blood Test- Understanding Barriers to Adherence

Official Title: Colonoscopy Followup After Positive Fecal Occult Blood Test- Understanding Barriers to Adherence

Study ID: NCT02534142

Interventions

Study Description

Brief Summary: Approximately 40% of members with a positive fecal occult blood result do not continue to followup colonoscopy in Meuhedet. The purpose of this study is to identify the structural, process, carer and patient related causes of undertreatment and suggest appropriate organisational interventions. Using both quantitative and qualitative methods, the investigators will identify organisational and personal barriers to completion of followup of positive FOBT.

Detailed Description: Colorectal cancer is the second in incidence and mortality among malignant tumors. Early detection of the disease is an effective means of reducing mortality and is possible through a fecal occult blood test. In the case of a positive result colonoscopy is required. In Israel, about 30% of people with a positive occult blood test do not perform a follow-up test. The aim of the study is to identify existing barriers to undergoing colonoscopy in a normal-risk population and improving adherence through different intervention mechanisms. At the end of the study we will describe effective intervention models at three levels: the patient, physicians and the organisation to improve early detection of colon cancer. Innovation of the Study * It will focus on the normal-risk population groups in Israel with a positive occult blood that didn't undergo colonoscopy. * Will identify the barriers in diverse populations * Will review the accessibility of diagnostic facilities forcolon cancer in Israel. * Will propose intervention programs to improve adherence at all levels in the process. Study Methods: A prospective study sing both both quantitative and qualitative methods in Meuhedet Health Services Target Population: Health system managers, physicians, and patients (a representative sample of 200 patients adhere colonoscopy and 600 that didn't adhere). Data collection databases from Meuhedet. The study will include questionnaires, focus groups and interviews. Stages of the study: 1. Describe the magnitude of the problem 2. Map the barriers to adherence with colonoscopy recommendations among patients, physicians and geographic availability of colonoscopies facilities. 3. Suggest intervention models for physicians, patients and organisations according to the information provided by data collection. 4. Recommendation to decision makers on the implementation of national policy intervention. Data processing: will use SPSS statistical analysis with the types of variables.

Keywords

Eligibility

Minimum Age: 51 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: Yes

Locations

Meuhedet, Tel Aviv, , Israel

Contact Details

Name: Revital Azulay, MSC

Affiliation: Meuhedet Health Care

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: